+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2019

  • ID: 4895277
  • Report
  • December 2019
  • Region: Global
  • 498 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AbaStar MDx Inc
  • Da An Gene Co Ltd
  • iGene Laboratory Pte Ltd
  • Nanosphere Inc
  • Roche Diagnostics GmbH
  • Tufts Medical Center
  • MORE
Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2019” provides an overview of Inborn Gene or Chromosome Alterations currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inborn Gene or Chromosome Alterations pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Inborn Gene or Chromosome Alterations under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbaStar MDx Inc
  • Da An Gene Co Ltd
  • iGene Laboratory Pte Ltd
  • Nanosphere Inc
  • Roche Diagnostics GmbH
  • Tufts Medical Center
  • MORE
1 Introduction
1.1 Inborn Gene or Chromosome Alterations Overview

2 Products under Development
2.1 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
2.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
2.3 Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
2.4 Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
2.5 Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

3 Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies
3.1 Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
3.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

4 Inborn Gene or Chromosome Alterations Companies and Product Overview

5 Inborn Gene or Chromosome Alterations- Recent Developments

6 Appendix

List of Tables
Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 8: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Molecular Diagnostic Test - Bipolar Disorder - Product Status
Table 10: Molecular Diagnostic Test - Bipolar Disorder - Product Description
Table 11: Molecular Diagnostic Test - Depression - Product Status
Table 12: Molecular Diagnostic Test - Depression - Product Description
Table 13: Molecular Diagnostic Test - Parkinson's Disease - Product Status
Table 14: Molecular Diagnostic Test - Parkinson's Disease - Product Description
Table 15: Molecular Diagnostic Test - Schizophrenia - Product Status
Table 16: Molecular Diagnostic Test - Schizophrenia - Product Description
Table 17: Adipomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Diagnostic Test - Type 2 Diabetes - Product Status
Table 19: Diagnostic Test - Type 2 Diabetes - Product Description
Table 20: Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Status
Table 22: Blood MicroRNA-Based AD Diagnostic And Prognostic Kit - Product Description
Table 23: Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Sensigene Trisomy 21 Laboratory Developed Test - Product Status
Table 25: Sensigene Trisomy 21 Laboratory Developed Test - Product Description
Table 26: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: SmartPanel - Product Status
Table 28: SmartPanel - Product Description
Table 29: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Diagnostic Test - IFN-Beta Resistance - Product Status
Table 31: Diagnostic Test - IFN-Beta Resistance - Product Description
Table 32: Amity University Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Prenatal Screening Kit - Product Status
Table 34: Prenatal Screening Kit - Product Description
Table 35: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 36: PDx Pre-Symptomatic Test - Product Status
Table 37: PDx Pre-Symptomatic Test - Product Description
Table 38: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Diagnostic Test - Neurodegenerative Disorders - Product Status
Table 40: Diagnostic Test - Neurodegenerative Disorders - Product Description
Table 41: Signature CF Expand - Product Status
Table 42: Signature CF Expand - Product Description
Table 43: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: SUMO Gene Test - Type 1 Diabetes - Product Status
Table 45: SUMO Gene Test - Type 1 Diabetes - Product Description
Table 46: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status
Table 48: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description
Table 49: DNA Guided Diagnostic Test - Diabetes - Product Status
Table 50: DNA Guided Diagnostic Test - Diabetes - Product Description
Table 51: DNA Guided Diagnostic Test - Obesity - Product Status
Table 52: DNA Guided Diagnostic Test - Obesity - Product Description
Table 53: INFINITI Factor II-V And MTHFR Assay - Product Status
Table 54: INFINITI Factor II-V And MTHFR Assay - Product Description
Table 55: INFINITI FMF Assay - Product Status
Table 56: INFINITI FMF Assay - Product Description
Table 57: INFINITI MTHFR Assay - Product Status
Table 58: INFINITI MTHFR Assay - Product Description

List of Figures
Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • AbaStar MDx Inc
  • Adipomics Inc
  • Advanced Genomic Technology, LLC
  • Agena Bioscience Inc
  • Alexion Pharmaceuticals Inc
  • Amarantus Bioscience Holdings Inc
  • Amity University
  • Arrayit Corporation
  • Asuragen Inc
  • Augusta University
  • AutoGenomics Inc
  • Avellino Lab USA Inc
  • Baylor College of Medicine
  • BioCeps (Inactive)
  • Biocept Inc
  • Biofidelity Ltd
  • CareDx Inc
  • Celula Inc
  • Center for Biomedical Research in Network of Rare Diseases
  • Children's Hospital Boston
  • Children's Hospital of Philadelphia
  • China Medical Technologies Inc (Inactive)
  • ChipCare Corp
  • Chronix Biomedical Inc
  • Cincinnati Children's Hospital Medical Center
  • Columbia University
  • Consejo Superior de Investigaciones Cientificas
  • Da An Gene Co Ltd
  • Decipher GenX, Inc.
  • DiaGenic ASA
  • Duke University
  • DxTerity Diagnostics Inc
  • Eone Diagnomics Genome Center Co Ltd
  • Epinex Diagnostics Inc
  • Fina Biotech SL
  • Firalis SAS
  • Fluidigm Corp
  • Fraunhofer Institute for Cell Therapy and Immunology
  • Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV
  • Fred Hutchinson Cancer Research Center
  • French National Institute of Health and Medical Research
  • Gene Solutions LLC
  • genedrive plc
  • Genentech Inc
  • Genisphere LLC
  • Genomic Vision SA
  • George Washington University
  • German Cancer Research Center
  • German Institute of Human Nutrition
  • Gilupi GmbH
  • GnuBIO Inc
  • Hadassah Medical Center
  • Hebrew University of Jerusalem
  • Helicos BioSciences Corporation
  • Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
  • Hummingbird Diagnostics GmbH
  • iGene Laboratory Pte Ltd
  • Illumina Inc
  • Indiana University
  • Interleukin Genetics Inc (Inactive)
  • Interpace Biosciences Inc
  • Johns Hopkins University
  • JS Genetics Inc
  • Juneau Biosciences LLC
  • KellBenx Inc (Inactive)
  • Laboratory Corp of America Holdings
  • Laval University
  • LifeCodexx AG
  • LineaGen Inc
  • Lucid Diagnostics Inc
  • Maastricht University Medical Center
  • Massachusetts Eye and Ear Infirmary
  • Max Delbruck Center for Molecular Medicine
  • McGill University
  • Medical Research Council
  • MeMed Diagnostics LTD
  • Multiplicom NV
  • Myriad Genetics Inc
  • Nanosphere Inc
  • National Institute of Immunohaematology
  • National University of Singapore
  • New York University School of Medicine
  • NewGene Ltd
  • NIPD Genetics
  • Northwestern University
  • Novomics Co Ltd
  • Oxford Biodynamics Plc
  • Oxford Gene Technology Ltd
  • ParagonDx LLC (Inactive)
  • PerkinElmer Inc
  • Population Bio Inc
  • Precipio Inc
  • PreCyte, Inc.
  • PredictImmune Ltd
  • Predictive Therapeutics LLC
  • Predigen Inc
  • Prognomix Inc
  • Proove BioScience Inc
  • Quest Diagnostics Inc
  • Randox Laboratories Ltd
  • RiboMed Biotechnologies Inc
  • Roche Diagnostics GmbH
  • Sansure Biotech Inc
  • Sapien Biosciences
  • Scipher Medicine Corp
  • Seattle Children's Hospital
  • Seegene Inc
  • Sequenom Inc
  • Sheba Medical Center
  • SkylineDx BV
  • Sophia Genetics SA
  • StellarGene Technologies Pvt Ltd
  • Strand Life Sciences Pvt Ltd
  • SUNY Upstate Medical University
  • Takeda Pharmaceuticals International AG
  • TAmiRNA GmbH
  • TBG Diagnostics Ltd
  • Tel Aviv University
  • Telo Genomics Corp
  • The Francis Crick Institute Ltd
  • TheraDiag SA
  • thromboDx
  • Transplant Genomics Inc
  • TrovaGene Inc
  • Tufts Medical Center
  • University Hospital of Cologne
  • University of Arizona
  • University of California San Diego
  • University of California San Francisco
  • University of Cambridge
  • University of Cape Town
  • University of Central Florida
  • University of Cincinnati
  • University of Colorado
  • University of Illinois at Chicago
  • University of Maryland
  • University of Melbourne
  • University of Michigan
  • University of Oxford
  • University of Pennsylvania
  • University of Pittsburgh
  • University of Turku
  • Vanadis Diagnostics AB
  • Vanderbilt University
  • Vanessa Research Inc
  • Virginia Commonwealth University
  • VitaPath Genetics, Inc.
  • VU University Medical Center
  • Weizmann Institute of Science
  • Yale University
Note: Product cover images may vary from those shown
Adroll
adroll